Thrombotic Microangiopathy
Hematology·MeSH: Thrombotic Microangiopathies
4 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| yartemlea | OMEROS CORP (OMER) |
Phase 3(1)
| Drug | Company |
|---|---|
| nomacopan | Akari Therapeutics Plc (AKTX) |
Phase 2(1)
| Drug | Company |
|---|---|
| narsoplimab | OMEROS CORP (OMER) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Thrombotic Microangiopathy?
BioSniper tracks 4 drugs in development for Thrombotic Microangiopathy across 3 companies.
How many clinical trials target Thrombotic Microangiopathy?
There are 1 clinical trial targeting Thrombotic Microangiopathy tracked by BioSniper.
Deep-dive into Thrombotic Microangiopathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis